We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
@miguelhernan.bsky.social 's Causal Inference What If book, but it seems that Harvard's SPH website no longer shows it.
Any idea how to get to the old page?
#EpiSky
@miguelhernan.bsky.social 's Causal Inference What If book, but it seems that Harvard's SPH website no longer shows it.
Any idea how to get to the old page?
#EpiSky
I've never used that peer review as any kind of signal or credential in judging a paper or deciding whether to read it.
Nearly all the papers I read are preprints.
I've never used that peer review as any kind of signal or credential in judging a paper or deciding whether to read it.
Nearly all the papers I read are preprints.